{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:37:25Z","timestamp":1760747845402,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"2-5","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.jsbmb.2005.01.001","type":"journal-article","created":{"date-parts":[[2005,4,13]],"date-time":"2005-04-13T14:20:31Z","timestamp":1113402031000},"page":"309-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of the efficacy and tolerability of a new once-a-week matricial estradiol transdermal system (Estrapatch\u00ae 40 and Estrapatch\u00ae 60) with a twice week system"],"prefix":"10.1016","volume":"93","author":[{"given":"Jean-Pierre","family":"Raynaud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"L\u00e9vrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquim","family":"Calaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e9ment","family":"Laur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"P\u00e9lissier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2005.01.001_bib1","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/S0002-9378(89)80001-8","article-title":"Estrogen replacement therapy: an overview","volume":"161","author":"Mishell","year":"1989","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2005.01.001_bib2","doi-asserted-by":"crossref","first-page":"59S","DOI":"10.1097\/00006250-199004001-00013","article-title":"The role and use particular of progestogens","volume":"75","author":"Whitehead","year":"1990","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2005.01.001_bib3","doi-asserted-by":"crossref","unstructured":"Consensus development conference: prophylaxis and treatment of osteoporosis, Am. J. Med. 90 (1991) 107\u2013110.","DOI":"10.1016\/0002-9343(91)90512-V"},{"key":"10.1016\/j.jsbmb.2005.01.001_bib4","first-page":"1828","article-title":"Increased risk of atherosclerosis in women after the menopause","volume":"298","author":"Witteman JCM","year":"1989","journal-title":"Brit. Med. J."},{"key":"10.1016\/j.jsbmb.2005.01.001_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/09513599809015597","article-title":"Clinical experience with a 7-day estrogen patch: principles and practice","volume":"12","author":"Notelovitz","year":"1998","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2005.01.001_bib6","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJM199110243251702","article-title":"Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins","volume":"325","author":"Walsh","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2005.01.001_bib7","first-page":"219","article-title":"Compliance problems with hormone replacement therapy","volume":"21","author":"Stumpf","year":"1994","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"10.1016\/j.jsbmb.2005.01.001_bib8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2165\/00003495-199040040-00006","article-title":"Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints","volume":"40","author":"Balfour","year":"1990","journal-title":"Drugs"},{"key":"10.1016\/j.jsbmb.2005.01.001_bib9","first-page":"5","article-title":"A randomized stud to compare the effectiveness, tolerability, and acceptability of two different transdermal estradiol therapies. The transdermal HRT investigators group","volume":"38","author":"Ary","year":"1993","journal-title":"Int. J. Fertil. Menopausal Stud."},{"key":"10.1016\/j.jsbmb.2005.01.001_bib10","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/0002-9378(95)90250-3","article-title":"Clinical experience with a seven-day estradiol transdermal system for estrogen replacement therapy","volume":"173","author":"Gordon","year":"1995","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2005.01.001_bib11","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/0002-9378(85)90568-X","article-title":"A double-blind comparative study of Estraderm and Premarin in the amelioration of post-menopausal symptoms","volume":"152","author":"Place","year":"1985","journal-title":"Am. J. Obset. Gynecol."},{"key":"10.1016\/j.jsbmb.2005.01.001_bib12","first-page":"179","article-title":"Developing the Fematrix transdermal patch","volume":"255","author":"Jenkins","year":"1995","journal-title":"The Pharm. J."},{"issue":"12","key":"10.1016\/j.jsbmb.2005.01.001_bib13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1001\/jama.1959.03010300001001","article-title":"Contemporary therapy of the menopausal syndrome","volume":"171","author":"Kupperman","year":"1959","journal-title":"The J. Am. Med. Assoc."},{"key":"10.1016\/j.jsbmb.2005.01.001_bib14","doi-asserted-by":"crossref","unstructured":"Million Women Study Collaborators, Breast cancer and hormone-replacement therapy in the Million Women Study, Lancet 362 (2003) 419\u2013427.","DOI":"10.1016\/S0140-6736(03)14065-2"},{"key":"10.1016\/j.jsbmb.2005.01.001_bib15","doi-asserted-by":"crossref","unstructured":"Writing Group for the Women's Health Initiative Investigators, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial, JAMA 288 (2002) 321\u2013333.","DOI":"10.1001\/jama.288.3.321"},{"key":"10.1016\/j.jsbmb.2005.01.001_bib16","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1067\/mob.2003.201","article-title":"Progestins and breast cancer","volume":"188","author":"Eden","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2005.01.001_bib17","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/jnci\/93.10.754","article-title":"Hormone replacement therapy after a diagnostic of breast cancer in relation to recurrence and mortality","volume":"93","author":"O\u2019Meara","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jsbmb.2005.01.001_bib18","first-page":"449","article-title":"Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States","volume":"7","author":"Willis","year":"1996","journal-title":"Cancer Causes Contr."},{"key":"10.1016\/j.jsbmb.2005.01.001_bib19","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00000421-200012000-00001","article-title":"Breast survival and hormone replacement therapy: a cohort analysis","volume":"23","author":"DiSaia","year":"2000","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.jsbmb.2005.01.001_bib20","first-page":"699","article-title":"Clinical and biological characteristics of breast cancers in post-menopausal women receiving hormone replacement therapy for menopause","volume":"6","author":"Salmon","year":"1999","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jsbmb.2005.01.001_bib21","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/(SICI)1097-0215(199806)79:3<278::AID-IJC12>3.0.CO;2-5","article-title":"Impact of menopausal hormone replacement therapy on clinical and laboratory characteristics of breast cancer","volume":"79","author":"Bonnier","year":"1998","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jsbmb.2005.01.001_bib22","first-page":"400","article-title":"The relationship between breast cancer survival and prior postmenopausal estrogen use","volume":"80","author":"Strickland","year":"1992","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2005.01.001_bib23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.maturitas.2004.06.007","article-title":"Exogenous progestagens and the human breast","volume":"49","author":"Sitruk-Ware","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.jsbmb.2005.01.001_bib24","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0029-7844(96)00272-4","article-title":"Efficacy and local tolerance of a low-dose 7-day matrix estradiol transdermal system in the treatment of menopausal vasomotor symptoms","volume":"88","author":"Speroff","year":"1996","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2005.01.001_bib25","unstructured":"The Transdermal HRT Investigators Group, A randomized study to compare tre effectiveness, tolerability and acceptability of two different transdermal estradiol replacement therapies, Int. J. Fert. 38 (1) (1993) 5\u201311."},{"key":"10.1016\/j.jsbmb.2005.01.001_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0378-5122(96)01068-7","article-title":"Comparison of two transdrmal systems (Oesclim\u00ae50 and Estraderm TTS\u00ae50) I. Tolerability, adhesion and efficacy","volume":"25","author":"Rozenbaum","year":"1996","journal-title":"Maturitas"},{"key":"10.1016\/j.jsbmb.2005.01.001_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0378-5122(96)01074-2","article-title":"Comparison of two transdrmal systems (Oesclim\u00ae50 and Estraderm TTS\u00ae50). II. Local skin tolerability","volume":"25","author":"Rozenbaum","year":"1996","journal-title":"Maturitas"},{"key":"10.1016\/j.jsbmb.2005.01.001_bib28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0378-5122(99)00099-7","article-title":"Efficacy and tolerability of a new 7-day transdermal estradiol patch versus placebo in hysterectomized women with postmenopausal complaints","volume":"34","author":"Von Holst","year":"2000","journal-title":"Maturitas"},{"key":"10.1016\/j.jsbmb.2005.01.001_bib29","first-page":"161","article-title":"Long-term tolerability and efficacy of Fem7*, a once-weekly transdermal system, in women with post-menopausal complaints","volume":"1","author":"Lutkie","year":"1998","journal-title":"J. Clin. Res."},{"key":"10.1016\/j.jsbmb.2005.01.001_bib30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0378-5122(96)01090-0","article-title":"Comparison of the local tolerability and adhesion of a new matrix system (Menorest\u00ae) for estradiol delivery with an established transdermal membrane system (Estraderm TTS\u00ae)","volume":"26","author":"Erianne","year":"1997","journal-title":"Maturitas"}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076005000208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076005000208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:49:47Z","timestamp":1760734187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076005000208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":30,"journal-issue":{"issue":"2-5","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0960076005000208"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2005.01.001","relation":{},"ISSN":["0960-0760"],"issn-type":[{"type":"print","value":"0960-0760"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the efficacy and tolerability of a new once-a-week matricial estradiol transdermal system (Estrapatch\u00ae 40 and Estrapatch\u00ae 60) with a twice week system","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2005.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}